220 related articles for article (PubMed ID: 24509240)
1. Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L.
Park IH; Kwon YC; Ryu WS; Ahn BY
Antiviral Res; 2014 Apr; 104():118-27. PubMed ID: 24509240
[TBL] [Abstract][Full Text] [Related]
2. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract][Full Text] [Related]
3. RNase L plays a role in the antiviral response to West Nile virus.
Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
[TBL] [Abstract][Full Text] [Related]
4. Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.
Li Y; Dong B; Wei Z; Silverman RH; Weiss SR
mBio; 2019 Nov; 10(6):. PubMed ID: 31719180
[TBL] [Abstract][Full Text] [Related]
5. RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.
Madden JC; Cui D; Brinton MA
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462564
[TBL] [Abstract][Full Text] [Related]
6. The 2-5A system in viral infection and apoptosis.
Castelli J; Wood KA; Youle RJ
Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.
Sánchez-Tacuba L; Rojas M; Arias CF; López S
J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041
[TBL] [Abstract][Full Text] [Related]
8. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity.
Asthana A; Gaughan C; Dong B; Weiss SR; Silverman RH
mBio; 2021 Aug; 12(4):e0178121. PubMed ID: 34372695
[TBL] [Abstract][Full Text] [Related]
9. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.
Li Y; Banerjee S; Wang Y; Goldstein SA; Dong B; Gaughan C; Silverman RH; Weiss SR
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2241-6. PubMed ID: 26858407
[TBL] [Abstract][Full Text] [Related]
10. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
[TBL] [Abstract][Full Text] [Related]
11. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of RNase L Is Required for Murine Coronavirus Replication in Kupffer Cells and Liver Sinusoidal Endothelial Cells but Not in Hepatocytes.
Li Y; Weiss SR
J Virol; 2016 Nov; 90(21):9826-9832. PubMed ID: 27558415
[TBL] [Abstract][Full Text] [Related]
13. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
[TBL] [Abstract][Full Text] [Related]
14. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.
Birdwell LD; Zalinger ZB; Li Y; Wright PW; Elliott R; Rose KM; Silverman RH; Weiss SR
J Virol; 2016 Jan; 90(6):3160-72. PubMed ID: 26739051
[TBL] [Abstract][Full Text] [Related]
15. Lineage A Betacoronavirus NS2 Proteins and the Homologous Torovirus Berne pp1a Carboxy-Terminal Domain Are Phosphodiesterases That Antagonize Activation of RNase L.
Goldstein SA; Thornbrough JM; Zhang R; Jha BK; Li Y; Elliott R; Quiroz-Figueroa K; Chen AI; Silverman RH; Weiss SR
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003490
[TBL] [Abstract][Full Text] [Related]
16. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.
Townsend HL; Jha BK; Han JQ; Maluf NK; Silverman RH; Barton DJ
RNA; 2008 Jun; 14(6):1026-36. PubMed ID: 18426919
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.
Yoshimura A; Nakanishi M; Yatome C; Kitade Y
J Biochem; 2002 Oct; 132(4):643-8. PubMed ID: 12359081
[TBL] [Abstract][Full Text] [Related]
18. The ribonuclease L-dependent antiviral roles of human 2',5'-oligoadenylate synthetase family members against hepatitis C virus.
Kwon YC; Kang JI; Hwang SB; Ahn BY
FEBS Lett; 2013 Jan; 587(2):156-64. PubMed ID: 23196181
[TBL] [Abstract][Full Text] [Related]
19. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
Guidotti LG; Morris A; Mendez H; Koch R; Silverman RH; Williams BR; Chisari FV
J Virol; 2002 Mar; 76(6):2617-21. PubMed ID: 11861827
[TBL] [Abstract][Full Text] [Related]
20. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.
Ibsen MS; Gad HH; Thavachelvam K; Boesen T; Desprès P; Hartmann R
J Virol; 2014 Dec; 88(24):14222-31. PubMed ID: 25275129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]